Eradivir
Biotechnology Research
West Lafayette, IN 309 followers
Safely guiding the human immune system to fight disease
About us
Our overarching goal is to focus the power of a patient’s immune system to kill both viruses and virus-infected cells, thereby eliminating a viral infection without causing damage to any uninfected cells. To achieve this, we employ a novel bispecific immunotherapy that eradicates a virus by tethering a patient’s cytotoxic immune cells specifically to the pathogenic virus or virus-infected cell, i.e. facilitating the rapid and selective destruction of the virus by the patient’s immune system. With a toolkit of these small bispecific molecules, we will be able to treat and potentially cure influenza, multiple coronaviruses, hepatitis B, HIV, and even cancers without damaging a patient’s healthy cells.
- Website
-
https://www.eradivir.com/
External link for Eradivir
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- West Lafayette, IN
- Type
- Privately Held
- Founded
- 2020
Locations
-
Primary
Get directions
West Lafayette, IN, US
Employees at Eradivir
-
Philip Low
Presidential Scholar for Drug Discovery and R.C. Corley Distinguished Professor of Chemistry, Purdue Univ.
-
Stewart Low
Biotech entrepreneur
-
Imrul Shahriar
Postdoctoral Research Associate @ Purdue University | PhD in Chemistry
-
Conrrad Nicholls, PhD, MPH
Scientist I - Eradivir Inc